This is a healthcare professional site

The information contained in the site is intended for Singapore healthcare professionals only. By selecting “Okay” below, you verify that you are a licensed Singapore healthcare professional.

Reporting test results

Learn how to accurately and consistently report CLDN18.2 expression

Both membranous stain intensity and percentage of tumour cells stained are critical for CLDN18.2 reporting1

In addition to membranous stain intensity and percentage of tumour cells stained, it is recommended that the biomarker report also include:

Integrated reporting:

  • The type of testing method used 
  • A description of the status of the sample, such as “positive,” “negative,” or “inconclusive” 
  • Any relevant notes or observations regarding the sample or results
overlayvideoimage
play-icon

reportingtestresults

reportingtestresults

closeicon
volumeicon

reportingtestresults

closeicon

reportingtestresults

transcript

How to Report CLDN18.2

Kristina A. Matkowskyj, MD, PhD

Pathologists play a critical role in driving consistent, integrated reporting that can help multidisciplinary teams develop the most effective treatment plans for patients

References: 1. Pellino A, Brignola S, Riello E, et al. Association of CLDN18 protein expression with clinicopathological features and prognosis in advanced gastric and gastroesophageal junction adenocarcinomas. J Pers Med (Epub) 10-26-2021.